BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30394973)

  • 1. A Patient With Schimmelpenning Syndrome and Mosaic KRAS Mutation.
    Mitchell BJ; Rogers GF; Wood BC
    J Craniofac Surg; 2019 Jan; 30(1):184-185. PubMed ID: 30394973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A postzygotic KRAS mutation in a patient with Schimmelpenning syndrome presenting with lipomatosis, renovascular hypertension, and diabetes mellitus.
    Nagatsuma M; Takasawa K; Yamauchi T; Nakagawa R; Mizuno T; Tanaka E; Yamamoto K; Uemura N; Kashimada K; Morio T
    J Hum Genet; 2019 Feb; 64(2):177-181. PubMed ID: 30443000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.
    Groesser L; Herschberger E; Ruetten A; Ruivenkamp C; Lopriore E; Zutt M; Langmann T; Singer S; Klingseisen L; Schneider-Brachert W; Toll A; Real FX; Landthaler M; Hafner C
    Nat Genet; 2012 Jun; 44(7):783-7. PubMed ID: 22683711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic KRAS mutation affecting codon 146 in linear sebaceous nevus syndrome.
    Kapoor S; Scanga HL; Reyes-Múgica M; Nischal KK
    Am J Med Genet A; 2021 Dec; 185(12):3825-3830. PubMed ID: 34254724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous Skeletal Hypophosphatemia Syndrome in Association with a Mosaic
    Park PG; Park E; Hyun HS; Kang HG; Ha IS; Cho TJ; Ko JM; Cheong HI
    Ann Clin Lab Sci; 2018 Sep; 48(5):665-669. PubMed ID: 30373874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS G12D mosaic mutation in a Chinese linear nevus sebaceous syndrome infant.
    Wang H; Qian Y; Wu B; Zhang P; Zhou W
    BMC Med Genet; 2015 Oct; 16():101. PubMed ID: 26521233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of KRAS mutation in a patient with linear nevus sebaceous syndrome: a case report.
    Pan C; Zhou X; Hong A; Fang F; Wang Y
    BMC Med Genomics; 2020 Dec; 13(1):188. PubMed ID: 33308209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schimmelpenning-Feuerstein-Mims syndrome induced by HRAS Gly12Ser somatic mosaic mutation: Case report and literature review.
    Ono H; Yamaguchi R; Arai M; Togi S; Ura H; Niida Y; Shimizu A
    J Dermatol; 2023 Sep; 50(9):1213-1215. PubMed ID: 37170693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inguinal lymph nodes agenesia in a patient with Schimmelpenning-Feuerstein-Mims syndrome with proven somatic KRAS mutation.
    Blanco Portals C; Gómez Tellado M; Del Pozo Losada J; Rodríguez Ruiz M
    Clin Exp Dermatol; 2022 Jan; 47(1):235-239. PubMed ID: 34435383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mosaic activating RAS mutations in nevus sebaceus and nevus sebaceus syndrome.
    Sun BK; Saggini A; Sarin KY; Kim J; Benjamin L; LeBoit PE; Khavari PA
    J Invest Dermatol; 2013 Mar; 133(3):824-827. PubMed ID: 23096709
    [No Abstract]   [Full Text] [Related]  

  • 11. Is Schimmelpenning Syndrome Associated with Intracranial Tumors? A Case Report.
    Chiang MC; McDowell MM; Weaver K; Broniscer A; Greene S
    Pediatr Neurosurg; 2019; 54(3):201-206. PubMed ID: 30879010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding mutational spectrum of HRAS by a patient with Schimmelpenning-Feuerstein-Mims syndrome.
    Luo Q; Zhang Q; Shen J; Guan W; Li M; Zhang J; Tan Z
    J Dermatol; 2021 Aug; 48(8):1273-1276. PubMed ID: 34109654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies.
    Chacon-Camacho OF; Lopez-Moreno D; Morales-Sanchez MA; Hofmann E; Pacheco-Quito M; Wieland I; Cortes-Gonzalez V; Villanueva-Mendoza C; Zenker M; Zenteno JC
    Mol Genet Genomic Med; 2019 May; 7(5):e625. PubMed ID: 30891959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MAP-kinase pathway activation in nevus sebaceous and Schimmelpenning syndrome].
    Dereure O
    Ann Dermatol Venereol; 2013 Apr; 140(4):326-7. PubMed ID: 23567237
    [No Abstract]   [Full Text] [Related]  

  • 15. Discordance for Schimmelpenning-Feuerstein-Mims syndrome in monochorionic twins supports the concept of a postzygotic mutation.
    Rijntjes-Jacobs EG; Lopriore E; Steggerda SJ; Kant SG; Walther FJ
    Am J Med Genet A; 2010 Nov; 152A(11):2816-9. PubMed ID: 20949522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-exome sequencing reveals somatic mutations in HRAS and KRAS, which cause nevus sebaceus.
    Levinsohn JL; Tian LC; Boyden LM; McNiff JM; Narayan D; Loring ES; Yun D; Sugarman JL; Overton JD; Mane SM; Lifton RP; Paller AS; Wagner AM; Antaya RJ; Choate KA
    J Invest Dermatol; 2013 Mar; 133(3):827-830. PubMed ID: 23096712
    [No Abstract]   [Full Text] [Related]  

  • 17. Nevus sebaceus is a mosaic RASopathy.
    Happle R
    J Invest Dermatol; 2013 Mar; 133(3):597-600. PubMed ID: 23399824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematised naevus sebaceus resulting from post-zygotic mutation in HRAS.
    Hsu CK; Saito R; Nanda A; Rashidghamat E; Al-Ajmi H; Lee JY; Hide M; McGrath JA
    Australas J Dermatol; 2017 Feb; 58(1):58-60. PubMed ID: 26400620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Papular nevus spilus syndrome: old and new aspects of a mosaic RASopathy.
    Torchia D; Happle R
    Eur J Dermatol; 2019 Feb; 29(1):2-5. PubMed ID: 30827948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mosaicism for oncogenic G12D KRAS mutation associated with epidermal nevus, polycystic kidneys and rhabdomyosarcoma.
    Bourdeaut F; Hérault A; Gentien D; Pierron G; Ballet S; Reynaud S; Paris R; Schleiermacher G; Baumann C; Philippe-Chomette P; Gauthier-Villars M; Peuchmaur M; Radvanyi F; Delattre O
    J Med Genet; 2010 Dec; 47(12):859-62. PubMed ID: 20805368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.